Skip to content
Brand AI

XBiotech

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Janssen completes acquisition of bermekimab rights

    The Janssen Pharmaceutical Companies of Johnson & Johnson completed the acquisition from XBiotech of all rights to investigational bermekimab, along with certain employees, for $750 million.

    Source